Anna De Bartolo - JoVE Visualize

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

International Immunopharmacology|February 26, 2021

Cateslytin abrogates lipopolysaccharide-induced cardiomyocyte injury by reducing inflammation and oxidative stress through toll like receptor 4 interactionCarmine Rocca, Anna De Bartolo, Fedora Grande, et al.

European Journal of Medicinal Chemistry|June 8, 2023

Discovery of a novel 1,3,4-oxadiazol-2-one-based NLRP3 inhibitor as a pharmacological agent to mitigate cardiac and metabolic complications in an experimental model of diet-induced metaflammationSimone Gastaldi, Carmine Rocca, Eleonora Gianquinto, et al.

Cells|April 13, 2023

Palmitate-Induced Cardiac Lipotoxicity Is Relieved by the Redox-Active Motif of SELENOT through Improving Mitochondrial Function and Regulating Metabolic StateCarmine Rocca, Anna De Bartolo, Rita Guzzi, et al.

Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

International Immunopharmacology|February 26, 2021

Cateslytin abrogates lipopolysaccharide-induced cardiomyocyte injury by reducing inflammation and oxidative stress through toll like receptor 4 interactionCarmine Rocca, Anna De Bartolo, Fedora Grande, et al.

European Journal of Medicinal Chemistry|June 8, 2023

Discovery of a novel 1,3,4-oxadiazol-2-one-based NLRP3 inhibitor as a pharmacological agent to mitigate cardiac and metabolic complications in an experimental model of diet-induced metaflammationSimone Gastaldi, Carmine Rocca, Eleonora Gianquinto, et al.

Cells|April 13, 2023

Palmitate-Induced Cardiac Lipotoxicity Is Relieved by the Redox-Active Motif of SELENOT through Improving Mitochondrial Function and Regulating Metabolic StateCarmine Rocca, Anna De Bartolo, Rita Guzzi, et al.

Pageof 3